Therapeutic Level IV. See page 128 for a complete description of levels of evidence.
Background Increasingly, acetabular retroversion is recognized in patients undergoing hip arthroplasty. Although prosthetic component positioning is not determined solely by native acetabular anatomy, acetabular retroversion presents a dilemma for component positioning if the surgeon implants the device in the anatomic position. Questions/purposes We asked (1) whether there is a difference in ROM between surface replacement arthroplasty (SRA) and THA in the retroverted acetabulum, and (2) does increased femoral anteversion improve ROM in the retroverted acetabulum? Methods Using a motion analysis tracking system, we determined the ROM of eight cadaveric hips and then created virtual CT-reconstructed bone models of each specimen. ROM was determined with THA and SRA systems virtually implanted with (1) the acetabular component placed in 45°a bduction and matching the acetabular anteversion (average 23°± 4°); (2) virtually retroverting the bony acetabulum 10°; and (3) after anteverting the THA femoral stem 10°.Results SRA resulted in ROM deficiencies in four of six maneuvers, averaging 25% to 29% in the normal and retroverted acetabular positions. THA restored ROM in all six positions in the normal acetabulum and in four of the six retroverted acetabula. The two deficient positions averaged 5% deficiency. THA with increased femoral stem anteversion restored ROM in five positions and showed only a 2% deficiency in the sixth position. Compared with the intact hip, ROM deficits were seen after SRA in the normal and retroverted acetabular positions and to a lesser extent for THA which can be improved with increased femoral stem anteversion. Conclusion Poor ROM may result after SRA if acetabular retroversion is present.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.